Egetis Therapeutics is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment.

Pharmaceutical

Egetis Therapeutics

Nicklas Westerholm

Azza Trad

Raymond Francot

Ben Willis

Eva Vestin

Karl Hård

Katayoun Welin-Berger

Anny Bedard

Nils Hallén

Christian Sonesson

Henrik Krook

Kristina Sjöblom Nygren

Yilmaz Mahshid

The board of directors at Egetis Therapeutics has a wealth of experience in the pharmaceutical industry. Members have served on the boards of directors of major companies such as LEO Pharma, Amolyt Pharma, and Galapagos. They have also held high-level positions within the industry, such as CEO of BioArctic and VP of AstraZeneca R&D. In addition, members of the board have founded or co-founded companies such as Rare Thyroid Therapeutics and Wilson Therapeutics.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Egetis Therapeutics

Leadership Team

CEO and Executive Team